Hawk Ridge Capital Management LP Purchases Shares of 423,900 The Cooper Companies, Inc. $COO

Key Points

• Hawk Ridge Capital Management LP has acquired a new position in The Cooper Companies, Inc., purchasing 423,900 shares valued at approximately $35.76 million.
• Institutional investors and hedge funds collectively own 24.39% of The Cooper Companies' stock, indicating significant interest from the investment community.
• This acquisition follows a positive quarterly earnings report, with Cooper Companies beating analysts' estimates by posting $1.10 earnings per share compared to the expected $1.07.

Hawk Ridge Capital Management LP bought a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 423,900 shares of the medical device company's stock, valued at approximately $35,756,000. Cooper Companies comprises approximately 1.7% of Hawk Ridge Capital Management LP's investment portfolio, making the stock its 23rd biggest position. Hawk Ridge Capital Management LP owned 0.21% of Cooper Companies at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in COO. Zions Bancorporation National Association UT purchased a new stake in Cooper Companies in the first quarter worth approximately $33,000. City Holding Co. purchased a new stake in Cooper Companies in the first quarter worth approximately $34,000. GKV Capital Management Co. Inc. purchased a new stake in Cooper Companies in the first quarter worth approximately $40,000. Larson Financial Group LLC boosted its holdings in Cooper Companies by 1,071.0% in the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares during the last quarter. Finally, HM Payson & Co. boosted its holdings in Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of COO traded up $0.70 during trading hours on Monday, reaching $68.79. 3,556,009 shares of the stock traded hands, compared to its average volume of 2,302,647. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $112.38. The company's 50-day moving average price is $71.99 and its two-hundred day moving average price is $76.57. The company has a market cap of $13.68 billion, a P/E ratio of 33.89, a price-to-earnings-growth ratio of 1.72 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. During the same quarter in the previous year, the company earned $0.96 EPS. Cooper Companies's revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

COO has been the topic of several research reports. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating on the stock in a report on Thursday, August 28th. Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the stock an "equal weight" rating in a research note on Thursday, August 28th. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. UBS Group upgraded shares of Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Finally, BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a research note on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $86.64.

Insider Activity

In other news, COO Gerard H. Warner III bought 1,450 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were bought at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the purchase, the chief operating officer owned 18,319 shares in the company, valued at $1,268,224.37. This represents a 8.60% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, COO Daniel G. Mcbride bought 3,000 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were purchased at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the purchase, the chief operating officer owned 63,120 shares in the company, valued at $4,105,324.80. This represents a 4.99% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 15,975 shares of company stock worth $1,079,566 in the last quarter. Corporate insiders own 1.98% of the company's stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.